Citius Pharmaceuticals, Inc. 10-Q, filed Feb 13, 2020: IDEA: XBRL DOCUMENT
Fda Refund |
3 Months Ended |
|---|---|
Dec. 31, 2019 | |
| FDA Refund [Abstract] | |
| FDA REFUND | 8. FDA REFUND
In November 2019, the Company received an additional $110,207 refund from the FDA for 2016 product and establishment fees because the fees paid by the Company exceeded the costs of the FDA's review of the associated applications. The Company recorded the $110,207 as other income during the three months ended December 31, 2019. |